Project Grant R01DK144783
- This federal Project Grant award of $1,500,424 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research to comprehensively characterize pretransplant operation strategies and local conditions across adult kidney transplant programs in the United States. The goal is to understand how certain pretransplant operation practices can impact patient access,...
- This federal Project Grant award of $842,633.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on developing an optimal prehabilitation program for kidney transplant candidates on hemodialysis. The grant aims to elicit expert opinion to identify kidney transplant-specific prehabilitation components and strategies to enhance enrollment and adherence...
- This $843,457 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK, CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) supports research to evaluate the impact of an ABO-compatible kidney allocation policy on reducing organ non-use and improving access for disadvantaged kidney transplant candidates. The key objectives are to: (I) estimate the impact of ABO-compatible allocation on non-use rates and transplant outcomes, (II)...
- This federal Project Grant award of $644,770 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research grant program (CFDA 93.855), will support research to determine the impact of immunosuppression on the risk of post-transplant lymphoproliferative disorder (PTLD) and Epstein-Barr virus (EBV) infection in kidney transplant recipients receiving EBV-seropositive donor organs. The project aims to identify modifiable risk factors,...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $200,000.00 to New York University School of Medicine to conduct a case-cohort study investigating novel determinants of risk for living kidney donors. The key objectives are to: 1) use qualitative research to inform recruitment strategies and messaging to maximize participation of...
- This federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $306,867 award to Dupage Medical Technology Inc. supports the development of a new drug to treat ischemia-reperfusion injury associated with kidney transplantation. The project aims to develop a therapy that can reduce inflammation and thrombosis without causing excessive...
- This Project Grant award of $860,513, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support a detailed analysis of the long-term health outcomes of living kidney donors (LKDs) at New York University (NYU). The key objectives are to: 1) Examine the natural history of kidney function, albuminuria, and systolic blood pressure in LKDs, adjusting for variables...
- This federal Project Grant award of $304,993 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to Immunowork LLC, located in Monrovia, CA. The award supports a research project to quantify peripheral blood antigen-specific memory B cells as a new biomarker in patients with PLA2R-associated membranous nephropathy, a common form of nephrotic syndrome. The goal...
- This federal Project Grant award of $330,997.00 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund a study on a remote home-based rehabilitation intervention for kidney transplant candidates. The University of Pennsylvania will conduct this research project with the goal of improving physical activity, function, and reducing frailty in kidney transplant...
- This $128,286 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research into the mechanisms of renal lipotoxicity and its contribution to the development of chronic kidney disease (CKD). The principal investigator will investigate the protective role of the FAF2 gene knockout in mitigating palmitate-induced lipotoxicity in...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research at New York University (NYU) to develop personalized immunosuppression regimens for kidney transplant recipients. The $847,371 award, with a project period from September 15, 2025 to July 31, 2030, will leverage a large nationwide electronic health record database to analyze individual treatment effects and identify optimal immunosuppression approaches to minimize adverse events while preventing rejection. The research aims to provide evidence-based guidance to clinicians for selecting the most appropriate immunosuppression protocols for individual kidney transplant recipients based on their risk profiles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $847.4k | 9/10/25 |